Susan Hasty, Publisher
Table of Contents . . . September 15th, 1997Non-Subscriber - Summaries Only
Therapy (HCV) - IFN-(alpha)/Ribavirin Combo Effective Following Liver Transplant
Disease Associations - Rare Osteosclerosis Syndrome May be Caused by Hepatitis C
Hepatitis Therapies - HCV Patent Portfolio for Protease Inhibitor Research Available
Industry News - HIV Viral Load, CMV, and HBV Test Distribution Rights Granted
Industry News (Acquisitions) - Acquisition of Viral Treatment Company Completed
Industry News (Joint Venture) - Agreement Announced for Buprenorphine Products Worldwide Marketing Rights
Industry News (Joint Venture) - Collaboration Targeting HPV and Hepatitis C Ends
Liver Disease - PAFT Member Companies Respond to Lancet Report
Pathogenesis (HCV) - Perihepatic Lymph Enlargement Linked to Liver Injury
Pediatrics (Hepatitis B) - BLA Submitted for Intron A for Use To Treat Chronic HBV
Testing (HBV) - Novel System for Screening Hepatitis B Virus Inhibitors Reported
Therapy (HCV) - Mutations Don't Predict IFN Response
Virology (HCV) - Peptide Epitope Could Be Promising Hepatitis C Vaccine
Antiviral Gene Therapy - "Molecular Therapy of Chronic Viral Hepatitis."
Antiviral Therapy (HCV) - "The Use of Interferon and Antiviral Substances in the Treatment of Chronic Hepatitis C."
Genetics (HGV) - "Processing of the Hepatitis G Virus Polyprotein."
Epidemiology (HCV) - "Epidemiology of Hepatitis C Virus Infection in an Area of Southern Italy."
Hepatitis/HIV Coinfection - "Hepatitis B and C in HIV-Infected Patients - Prevalence and Prognostic Value."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.